Company intelligence / Profile preview

Bright Therapeutics

Ownership: Private
Development stage: Commercial

Overview

Bright Therapeutics develops specialized, clinically validated digital health products designed to improve patient outcomes, equip providers with actionable insights, and offer cost-effective solutions for payers. Their tools are built from rigorous clinical research and frontline provider input. Engagement metrics indicate strong uptake of their solutions.

Therapeutic areas: Other
Modalities: Non-pharmacological therapyDigital therapeutic (based on software products; not drugs or biologics)
Industry: Digital Health Medical Devices

Drug pipeline

7 assets

Recovery Path

Commercial

Indications: Addiction

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Bright Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bright Therapeutics.

Explore the full profile